Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease.

Antonios DourosYing CuiRobert W PlattKristian B FilionGiada SebastianiChristel Renoux

Published in: British journal of clinical pharmacology (2021)

Most NVAF patients with liver disease initiated treatment with DOACs. Long-term persistence with DOACs was higher than with VKAs but remained relatively low.

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism
oral anticoagulants
catheter ablation
left atrial appendage
left atrial
heart failure
mitral valve